Catalog Number 545050501 |
Device Problem
Loss of or Failure to Bond (1068)
|
Patient Problem
Insufficient Information (4580)
|
Event Date 03/05/2024 |
Event Type
Injury
|
Event Description
|
The patient was revised due to femoral loosening at the unknown interface.Depuy cement was used.Doi: unknown.Dor: (b)(6) 2024.Affected side: right knee.
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).Dmf# - 13704.Trade name gentamicin sulphate.Active ingredient(s) gentamicin sulphate.Dosage form - powder.Strength 1.0g active in our cements.This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes, or its employees that the report constitutes an admission that the product, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
Event Description
|
Additional information was received: -there was no surgical delay.- it was indicated that there was loosening.On what interface did the loosening occurred? stem bone interface.-there was no alleged deficiency to the other reported devices.
|
|
Manufacturer Narrative
|
Product complaint #: (b)(4).Investigation summary: an analysis of the product could not be performed since a physical sample was not received for evaluation.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.Additional complaint information monitoring for potential safety signals will be conducted through complaint trending as part of the post-market surveillance.However, if the product is received at a later date, the investigation will be updated as applicable.
|
|
Event Description
|
Additional information was received: 1.As the der states, "femoral loosening" which is non-specific and we need to determine which parts of the femoral construct were loose: a.Was there loosening of the sleeve? if yes, was the sleeve cemented, non-cemented, or both? no.B.Was the femoral stem loosened? if yes, was the stem cemented or non cemented? yes stem was loose and it was cemented? yes.
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthese joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthese joint reconstruction, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
Search Alerts/Recalls
|